176 related articles for article (PubMed ID: 27560284)
1. New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment.
Brullo C; Ricciarelli R; Prickaerts J; Arancio O; Massa M; Rotolo C; Romussi A; Rebosio C; Marengo B; Pronzato MA; van Hagen BTJ; van Goethem NP; D'Ursi P; Orro A; Milanesi L; Guariento S; Cichero E; Fossa P; Fedele E; Bruno O
Eur J Med Chem; 2016 Nov; 124():82-102. PubMed ID: 27560284
[TBL] [Abstract][Full Text] [Related]
2. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation, and molecular modeling of new 3-(cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) related phosphodiesterase 4D (PDE4D) inhibitors.
Brullo C; Massa M; Rocca M; Rotolo C; Guariento S; Rivera D; Ricciarelli R; Fedele E; Fossa P; Bruno O
J Med Chem; 2014 Aug; 57(16):7061-72. PubMed ID: 25126889
[TBL] [Abstract][Full Text] [Related]
4. GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses.
Bruno O; Fedele E; Prickaerts J; Parker LA; Canepa E; Brullo C; Cavallero A; Gardella E; Balbi A; Domenicotti C; Bollen E; Gijselaers HJ; Vanmierlo T; Erb K; Limebeer CL; Argellati F; Marinari UM; Pronzato MA; Ricciarelli R
Br J Pharmacol; 2011 Dec; 164(8):2054-63. PubMed ID: 21649644
[TBL] [Abstract][Full Text] [Related]
5. Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease.
Ricciarelli R; Brullo C; Prickaerts J; Arancio O; Villa C; Rebosio C; Calcagno E; Balbi M; van Hagen BT; Argyrousi EK; Zhang H; Pronzato MA; Bruno O; Fedele E
Sci Rep; 2017 Apr; 7():46320. PubMed ID: 28402318
[TBL] [Abstract][Full Text] [Related]
6. Molecular Bases of PDE4D Inhibition by Memory-Enhancing GEBR Library Compounds.
Prosdocimi T; Mollica L; Donini S; Semrau MS; Lucarelli AP; Aiolfi E; Cavalli A; Storici P; Alfei S; Brullo C; Bruno O; Parisini E
Biochemistry; 2018 May; 57(19):2876-2888. PubMed ID: 29652483
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
[TBL] [Abstract][Full Text] [Related]
8. PDE4D inhibitors: a potential strategy for the treatment of memory impairment?
Bruno O; Ricciarelli R; Prickaerts J; Parker L; Fedele E
Neuropharmacology; 2014 Oct; 85():290-2. PubMed ID: 24942130
[No Abstract] [Full Text] [Related]
9. Design, synthesis, biological evaluation and structural characterization of novel GEBR library PDE4D inhibitors.
Brullo C; Rapetti F; Abbate S; Prosdocimi T; Torretta A; Semrau M; Massa M; Alfei S; Storici P; Parisini E; Bruno O
Eur J Med Chem; 2021 Nov; 223():113638. PubMed ID: 34171658
[TBL] [Abstract][Full Text] [Related]
10. New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.
Guariento S; Bruno O; Fossa P; Cichero E
Mol Divers; 2016 Feb; 20(1):77-92. PubMed ID: 26290462
[TBL] [Abstract][Full Text] [Related]
11. Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice.
Zhang C; Xu Y; Chowdhary A; Fox D; Gurney ME; Zhang HT; Auerbach BD; Salvi RJ; Yang M; Li G; O'Donnell JM
Neuropsychopharmacology; 2018 Oct; 43(11):2299-2309. PubMed ID: 30131563
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice.
Wang ZZ; Yang WX; Zhang Y; Zhao N; Zhang YZ; Liu YQ; Xu Y; Wilson SP; O'Donnell JM; Zhang HT; Li YF
Sci Rep; 2015 Jul; 5():11332. PubMed ID: 26161529
[TBL] [Abstract][Full Text] [Related]
13. Insight into GEBR-32a: Chiral Resolution, Absolute Configuration and Enantiopreference in PDE4D Inhibition.
Cavalloro V; Russo K; Vasile F; Pignataro L; Torretta A; Donini S; Semrau MS; Storici P; Rossi D; Rapetti F; Brullo C; Parisini E; Bruno O; Collina S
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093112
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis.
Kaname T; Ki CS; Niikawa N; Baillie GS; Day JP; Yamamura K; Ohta T; Nishimura G; Mastuura N; Kim OH; Sohn YB; Kim HW; Cho SY; Ko AR; Lee JY; Kim HW; Ryu SH; Rhee H; Yang KS; Joo K; Lee J; Kim CH; Cho KH; Kim D; Yanagi K; Naritomi K; Yoshiura K; Kondoh T; Nii E; Tonoki H; Houslay MD; Jin DK
Cell Signal; 2014 Nov; 26(11):2446-59. PubMed ID: 25064455
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Song G; Zhao D; Hu D; Li Y; Jin H; Cui Z
Bioorg Med Chem Lett; 2015 Oct; 25(20):4610-4. PubMed ID: 26320621
[TBL] [Abstract][Full Text] [Related]
16. Discovery of triazines as potent, selective and orally active PDE4 inhibitors.
Gewald R; Grunwald C; Egerland U
Bioorg Med Chem Lett; 2013 Aug; 23(15):4308-14. PubMed ID: 23806553
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Role of Water Molecules in the Ligand Binding Domain of PDE4B and PDE4D: Virtual Screening Based Molecular Docking of Some Active Scaffolds.
Singh P; Mishra M; Agarwal S; Sau S; Iyer AK; Kashaw SK
Curr Comput Aided Drug Des; 2019; 15(4):334-366. PubMed ID: 30394213
[TBL] [Abstract][Full Text] [Related]
18. Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4).
Cameron RT; Coleman RG; Day JP; Yalla KC; Houslay MD; Adams DR; Shoichet BK; Baillie GS
Biochem Pharmacol; 2013 May; 85(9):1297-305. PubMed ID: 23473803
[TBL] [Abstract][Full Text] [Related]
19. Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice.
Rutten K; Misner DL; Works M; Blokland A; Novak TJ; Santarelli L; Wallace TL
Eur J Neurosci; 2008 Aug; 28(3):625-32. PubMed ID: 18702734
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors.
Nunes IK; de Souza ET; Cardozo SV; Carvalho VF; Romeiro NC; Silva PM; Martins MA; Barreiro EJ; Lima LM
PLoS One; 2016; 11(10):e0162895. PubMed ID: 27695125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
